Specializing in robotic urologic oncology and minimally invasive surgery, this physician has more than 15 years of experience treating prostate, kidney, bladder, and upper tract urothelial cancers. His clinical practice includes robotic-assisted laparoscopic prostatectomy, robotic cystectomy, partial nephrectomy, salvage prostatectomy, retroperitoneal lymphadenectomy, reconstructive urology, and minimally invasive management of complex genitourinary conditions. He also has prior expert witness experience involving consultations and depositions.

His research and clinical leadership have focused heavily on robotic surgical technologies, renal cell carcinoma, prostate cancer therapies, bladder cancer management, fluorescence-guided surgery, and functional outcomes following robotic procedures. He has directed fellowship training programs in robotic and urologic oncology, co-led a kidney cancer program, and participated in numerous clinical trials involving targeted therapies, ablative technologies, testosterone replacement therapy, overactive bladder treatment, and intraoperative near-infrared imaging using robotic surgical systems.

Alongside his surgical and academic responsibilities, he has authored extensive peer-reviewed publications and presentations involving robotic surgery, renal tumors, radical cystectomy, robotic partial nephrectomy, salvage prostatectomy, urinary diversion procedures, and metastatic genitourinary disease. He holds a Bachelor of Science in Anthropology, earned summa cum laude with departmental honors, and a Doctor of Medicine (M.D.). He is board certified in urology, maintains active medical licensure and fluoroscopy supervision certification, and is a Fellow of the American College of Surgeons (FACS). He serves on national kidney and testicular cancer guideline panels and maintains active membership in organizations dedicated to urologic oncology, robotic surgery, and clinical oncology. He has also served as a reviewer for a peer-reviewed journal in robotic surgery and as a member of an editorial advisory board for a national cancer education resource, reflecting his ongoing leadership in urologic oncology and robotic surgical innovation.